Zobrazeno 1 - 2
of 2
pro vyhledávání: '"G. Dewey Wilbanks"'
Autor:
Siriruk Changrob, Peter J. Halfmann, Hejun Liu, Jonathan L. Torres, Joshua J.C. McGrath, Gabriel Ozorowski, Lei Li, G. Dewey Wilbanks, Makoto Kuroda, Tadashi Maemura, Min Huang, Nai-Ying Zheng, Hannah L. Turner, Steven A. Erickson, Yanbin Fu, Atsuhiro Yasuhara, Gagandeep Singh, Brian Monahan, Jacob Mauldin, Komal Srivastava, Viviana Simon, Florian Krammer, D. Noah Sather, Andrew B. Ward, Ian A. Wilson, Yoshihiro Kawaoka, Patrick C. Wilson
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 8 (2023)
The rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants has emphasized the need to identify antibodies with broad neutralizing capabilities to inform future monoclonal therapies and vaccination strateg
Externí odkaz:
https://doaj.org/article/18492c6385494d56a88d5b525e7475bc
Autor:
Siriruk Changrob, Peter J. Halfmann, Hejun Liu, Jonathan L. Torres, Joshua J.C. McGrath, Gabriel Ozorowski, Lei Li, Makoto Kuroda, Tadashi Maemura, Min Huang, G. Dewey Wilbanks, Nai-Ying Zheng, Hannah L. Turner, Steven A. Erickson, Yanbin Fu, Gagandeep Singh, Florian Krammer, D. Noah Sather, Andrew B. Ward, Ian A. Wilson, Yoshihiro Kawaoka, Patrick C. Wilson
SummaryThe rapid evolution of SARS-CoV-2 Omicron variants has emphasized the need to identify antibodies with broad neutralizing capabilities to inform future monoclonal therapies and vaccination strategies. Herein, we identify S728-1157, a broadly n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02a32d6672a2cfb3ef945519bb593d93
https://doi.org/10.1101/2022.10.31.514592
https://doi.org/10.1101/2022.10.31.514592
